US panel narrowly recommends J&J's Doribax for pneumonia
This article was originally published in Scrip
Executive Summary
The USFDA's advisors on July 16th narrowly recommended approval ofJohnson & Johnson's carbapenem antibiotic Doribax (doripenem) for hospital-acquired pneumonia.